干扰素及受体

分类介绍

细胞因子与生长因子在淋巴细胞、肥大细胞及内皮细胞等多种细胞中参与细胞生长、分化与活化调控。本分类涵盖白介素、干扰素、趋化因子、TNF 超家族、集落刺激因子及 TGF-β、VEGF、EGF、FGF 等生长因子家族，适用于免疫学、细胞生物学与药物研发。

产品特点

·多物种覆盖（人、小鼠、大鼠、食蟹猴等）
·多种表达系统（E. coli、HEK293、CHO、P. pastoris、Sf9 等）
·高纯度与低内毒素，部分产品提供活性数据
·完整 COA、SDS 及 QC 报告，支持申报与溯源

主要应用场景

·免疫调节与炎症机制研究
·干细胞与类器官培养
·细胞治疗与抗体药物筛选
·肿瘤免疫与信号通路研究

干扰素及受体重组蛋白 (1715)

NYESO1-HP009

Human NY-ESO-1 TCR&CD3 Complex VLP

种属: Human
表达系统: Human; HEK293; NY-ESO-1 specific TCR (1G4c113), CD3ε&CD3γ, CD3ε&CD3δ, and CD3ζ dimers

蛋白结构

NY-ESO-1 TCR&CD3 Complex VLPCore

N-terminusC-terminus

目录号	产品名 / 同用名	种属	表达系统	蛋白结构
NYESO1-HP009	Human NY-ESO-1 TCR&CD3 Complex VLP	Human	Human; HEK293; NY-ESO-1 specific TCR (1G4c113), CD3ε&CD3γ, CD3ε&CD3δ, and CD3ζ dimers	NY-ESO-1 TCR&CD3 Complex VLPCore N-terminusC-terminus
MAGEA4-HP004	Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Tetramer Protein	Human	Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and GVYDGREHTV peptide	HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305
MAGEA4-HB003	Biotinylated Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Monomer Protein	Human	Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and GVYDGREHTV peptide	HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
MAGEA3-HB004	Biotinylated Human HLA-A*02:01&B2M&MAGE-A3 (KVAELVHFL) Monomer Protein	Human	Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and KVAELVHFL peptide	HLA-A*02:01&B2M&MAGE-A3 (KVAELVHFL) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
LGR4-HP001	Human LGR-4 Nanodisc Protein	Human	Recombinant Human LGR-4 Nanodisc is expressed from HEK293 with His tag at the C-terminus. It contains Met1-Asp951 (accession: Q9BXB1-1).	LGR-4 NanodiscHis N-terminusC-terminus AA segmentMet1-Asp951
KRASG12D-HP003	Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein	Human	Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGADGVGK peptide	HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) MonomerHis N-terminusC-terminus AA segmentGly25-Thr305
IGE-AB001	Anti-IgE Antibody (Omalizumab Biosimilar)	Human	Human/Cynomolgus; HEK293; Human IgG1-Kappa	Anti-IgECore N-terminusC-terminus
HLAE0103-HB003	Biotinylated Human Peptide Ready HLA-E*01:03&B2M Monomer Protein	Human	Human; HEK293; Gly22-Thr302(HLA-E*01:03) & Ile21-Met119(B2M)	Peptide Ready HLA-E*01:03&B2M MonomerAviHis N-terminusC-terminus AA segmentGly22-Thr302
HLAA3303-HB002	Biotinylated Human Peptide Ready HLA-A*33:03&B2M Monomer Protein, Ultra Low Endotoxin	Human	Human; HEK293; Gly25-Thr305(HLA-A*33:03) & Ile21-Met119(B2M)	Peptide Ready HLA-A*33:03&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
HLAA2402-HB002	Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein, Ultra Low Endotoxin	Human	Human; HEK293; Gly25-Thr305(HLA-A*24:02) & Ile21-Met119(B2M)	Peptide Ready HLA-A*24:02&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
HLAA2402-HB001	Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein	Human	Human; HEK293; Gly25-Thr305(HLA-A*24:02) & Ile21-Met119(B2M)	Peptide Ready HLA-A*24:02&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
HLAA1101-HP005	Human Peptide Ready HLA-A*11:01&B2M Monomer Protein, Ultra Low Endotoxin	Human	Human; HEK293; Gly25-Thr305 (HLA-A*11:01) & Ile21-Met119 (B2M)	Peptide Ready HLA-A*11:01&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
HLAA0301-HB004	Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer Protein, Ultra Low Endotoxin	Human	Human; HEK293; Gly25-Thr305(HLA-A*03:01) & Ile21-Met119(B2M)	Peptide Ready HLA-A*03:01&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
HLAA0201-HB015	Biotinylated Human Peptide Ready HLA-A*02:01&B2M Monomer Protein, Ultra Low Endotoxin	Human	Human; HEK293; Gly25-Thr305(HLA-A*02:01) & Ile21-Met119(B2M)	Peptide Ready HLA-A*02:01&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
HBV-HP002	Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein	Human	Human; HEK293; Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M) and FLLTRILTI peptide	HLA-A*02:01&B2M&HBV (FLLTRILTI) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305
GLP1R-HP001	Human GLP-1R Nanodisc Protein	Human	Recombinant Human GLP-1R Nanodisc is expressed from HEK293 with His tag at the C-terminus (FITC-equivalent protein is fused on cytoplasmic part). It contains Met1-Ser463 (accession: P43220).	GLP-1R NanodiscHis N-terminusC-terminus AA segmentMet1-Ser463
FGFR4-HP001	Non-biotinylated Human FGFR4 Protein	Human	Human; HEK293; Recombinant Human FGFR4 Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Leu22-Asp369 (UniProt accession: P22455-1).	Non-biotinylated Human FGFR4AviHis N-terminusC-terminus AA segmentLeu22-Asp369
FCRN-HB001	Biotinylated Human FcRn Protein	Human	Human; HEK293; Recombinant Biotinylated Human FcRn Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Ala24-Ser297(FCGRT)&Ile21-Met119(B2M) (accession: P55899(FCGRT) & P61769((B2M)).	FcRnAviFcHis N-terminusC-terminus AA segmentAla24-Ser297
CLDN182-AB001	Anti-Claudin 18.2 Antibody (Zolbetuximab Biosimilar)	Human	Human; HEK293; Human IgG1-Kappa	Anti-Claudin 18.2Core N-terminusC-terminus
CD3D-HP001	Human CD3D/CD3 delta Protein	Human	Human; HEK293; Recombinant Human CD3D/CD3 delta Protein is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Phe22-Ala105 (UniProt accession: P04234-1).	CD3D/CD3 deltaHis N-terminusC-terminus AA segmentPhe22-Ala105

分类介绍

产品特点

主要应用场景

种属 (Species)

标签 (Tag)

表达系统 (Expression System)